Skip to main content
. 2019 Jun 4;8(3):385–386. doi: 10.1089/jayao.2018.0141

FIG. 1.

FIG. 1.

Two-year change in left ventricular ejection fraction (A) and E-wave velocity (B) in osteosarcoma patients receiving anthracyclines with dexrazoxane (gray) and without dexrazoxane (white). LVEF, left ventricular ejection fraction.